Research output per year
Research output per year
Personal profile
Expertises
Oncology; Sarcoma; Merkel Cell Carcinoma
Immuno-Oncology; cancer immunotherapy; T-cells
Main research areas
Immuno-Oncology; translational research; T cell based immunotherapy
Established methods for TIL based adoptive transfer in malignant melanoma and Head & Neck cancer. Pilot trial of TIL based therapy in patients with malignant melanoma.
Current research
Soft tissue sarcoma: supervisor on preclinical ph.d project (Morten Nielsen MD, PhD student) establishing the role of and evidence for TIL based immunotherapy in sarcoma patients.
Merkel Cell Carcinoma: A prospective, non-interventional study identifying clinical, pathological and immune-oncological characteristics of patients with Merkel Cell Carcinoma.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Niels Junker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma
Nielsen, M., Monberg, T., Sundvold, V., Albieri, B., Hovgaard, D., Petersen, M. M., Krarup-Hansen, A., Met, Ö., Camilio, K., Clancy, T., Stratford, R., Sveinbjornsson, B., Rekdal, Ø., Junker, N. & Svane, I. M., 2024, In: OncoImmunology. 13, 1, p. 1-11 11 p., 2290900.Research output: Contribution to journal › Journal article › Research › peer-review
-
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma
Schöffski, P., Bahleda, R., Wagner, A. J., Burgess, M. A., Junker, N., Chisamore, M., Peterson, P., Szpurka, A. M., Ceccarelli, M. & Tap, W. D., 1 Sept 2023, In: Clinical Cancer Research. 29, 17, p. 3220-3228 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment
Fjæstad, K. Y., Rømer, A. M. A., Goitea, V., Johansen, A. Z., Thorseth, M.-L., Carretta, M., Engelholm, L. H., Grøntved, L., Junker, N. & Madsen, D. H., Feb 2022, In: Oncogene. 41, 9, p. 1364-1375 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Merkelcellekarcinom
Translated title of the contribution :Merkel cell carcinoma Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
Brinch, C. M., Hogdall, E., Junker, N., Moeller, H. J., Sandfeld-Paulsen, B., de Heer, P., Penninga, L., Rossen, P. B., Krarup-Hansen, A. & Aggerholm-Pedersen, N., 23 Nov 2022, In: Cancers. 14, 23, 5753.Research output: Contribution to journal › Journal article › Research › peer-review